Blood
Adam Kennedy link to other pubmed listings for this student
2003 Feb 1;101(3):1071-9. Epub 2002 Sep 5
An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab.
Sanja Arandjelovic link to other pubmed listings for this student
2008 Jun 1;111(11):5316-25. Epub 2008 Mar 27.
Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor.